Goldman Sachs Maintains Neutral on Cerence, Raises Price Target to $9
Benzinga Newsdesk 6 months ago
NewsPrice TargetAnalyst Ratings
Goldman Sachs analyst Mark Delaney maintains Cerence (NASDAQ:CRNC) with a Neutral and raises the price target from $8 to $9.
Goldman Sachs analyst Mark Delaney maintains Cerence (NASDAQ:CRNC) with a Neutral and raises the price target from $8 to $9.